Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07495852
PHASE3
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Sponsor: Glaukos Corporation
View on ClinicalTrials.gov
Summary
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Official title: Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
510
Start Date
2026-02-17
Completion Date
2032-03
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Interventions
DRUG
Gen 2 Travoprost Intracameral Implant
Travoprost
DRUG
Timolol eye drops 0.5%
Timolol 0.5%
PROCEDURE
Sham Procedure
Sham implant administration
OTHER
placebo eye drops
Artificial Tears
Locations (1)
Glaukos Investigative Site
Dothan, Alabama, United States